bizjournals.com Health Care:Pharmaceuticals headlines 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Ginkgo Bioworks acquires assets from struggling North Carolina firm
The cash-strapped AgBiome is selling more assets after last year telling state officials it may have to lay off its entire staff. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 15, 2024 Category: Pharmaceuticals Authors: Zac Ezzone Source Type: news
Raleigh hedge fund urges board shakeup at Novavax
A Raleigh investment firm is pushing for changes at a struggling vaccine developer that lost hundreds of millions of dollars last year. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 15, 2024 Category: Pharmaceuticals Authors: Zac Ezzone Source Type: news
FDA pauses Watertown biotech ’s schizophrenia trial
The U.S. Food and Drug Administration placed a clinical hold on a Watertown biotech ’s schizophrenia drug trial after new pre-clinical data showed convulsions in rabbits. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 15, 2024 Category: Pharmaceuticals Authors: Hannah Green Source Type: news
Safeguarding the whole health of Georgia ’s children
Every child has a right to safety and well-being. And yet, sadly, youth across the nation and around the world needlessly suffer violence, exploitation and neglect at the hands of adults entrusted to care for them.
In Georgia, nearly 107,000 cases of child abuse and neglect were reported in 2021. This excludes unreported incidences of Adverse Childhood Experiences (ACEs) such as sex trafficking, sexual abuse, physical abuse, psychological abuse or neglect. Equally jolting, 58% of adults in Georgia … (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 15, 2024 Category: Pharmaceuticals Authors: Bobby Cagle Source Type: news
Health system owner to pump more than $180M into South Texas
New funding will address health challenges, the digital divide and initiatives addressing systemic inequities. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 15, 2024 Category: Pharmaceuticals Authors: W. Scott Bailey Source Type: news
Hacker gang claims it has Change Healthcare data from cyberattack
Security experts are divided on whether the hackers are telling the truth or attempting a scam. A report Friday reveals that the threat looks credible. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 15, 2024 Category: Pharmaceuticals Authors: Mark Reilly Source Type: news
Health care companies turn to Buffalo-area colleges for talent
Partnerships with local universities are crucial for building a talent pipeline in health care, from nursing to medical device production. Here are a couple local partnerships that are growing. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 15, 2024 Category: Pharmaceuticals Authors: Katie Anderson Source Type: news
Commentary: Pharmacy benefit managers, not Big Pharma, responsible for high drug prices
The media has written extensively about GSK's decision to stop selling its branded asthma inhaler Flovent and to replace it with a generic version. Outlets such as Fox Business and U.S. News and World Report have reported on the topic, but, remarkably, the stories fail to enlighten readers on why GSK chose to switch to a cheaper generic version of its inhaler.
Many of the stories seem to have been written by the same reporters, with industry critics regularly quoted and the blame falling predictably … (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 15, 2024 Category: Pharmaceuticals Authors: William S. Smith | Robert Popovian Source Type: news
Empowering women ’s heart health: The Circle of Red Society
For 100 years, the American Heart Association has saved and improved lives, pioneered scientific discovery and advocated for healthy communities. As the Association enters its second century of life-saving work, these efforts remain critical as cardiovascular disease continues to be the number one killer in the United States, claiming more lives than all cancers combined.*
For women, the focus on heart health is more critical than ever. Despite significant strides in medical research, women remain … (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 15, 2024 Category: Pharmaceuticals Authors: American Heart Association Source Type: news
Emergency department chief on how Holy Cross Health plans to bring efficiency to emergency services in Silver Spring
Last year, Holy Cross Health saw a 20% increase in patients coming to the emergency department. With more than 75,000 annual visits, the health system strives to find ways to alleviate overcrowding and provide dedicated sections for behavioral health patients and continued support for seniors.
The health system expects to be able to achieve those goals with the help of a $2.5 million gift from the Nora Roberts Foundation, a steadfast advocate for creating an equitable and safe world. The commitment … (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 15, 2024 Category: Pharmaceuticals Authors: Laura Newpoff Source Type: news
March for Babies draws support from food and health companies
March of Dimes Hawaii Executive Director Candice Fajardo is gearing up for the annual March for Babies: A Mother of a Movement event on May 4. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 13, 2024 Category: Pharmaceuticals Authors: Kelsey Kukaua Medeiros Source Type: news
OHSU leaders shed more light on plans to improve financial picture
The plan is to grow revenue from treating the sickest, most complex patients. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 12, 2024 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news
Adaptimmune shares drop as Genentech terminates deal once valued at $3 billion
Adaptimmune and Genentech inked the cell therapy research and licensing pact in 2021. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 12, 2024 Category: Pharmaceuticals Authors: Ryan Sharrow Source Type: news
ZoomCare gears up to take Medicare, expand primary care offerings
Until now ZoomCare took only cash or private insurance, not government payers. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 12, 2024 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news
Adaptimmune shares drop as Genentech terminates potential $3B deal
Adaptimmune and Genentech reached the research and licensing agreement in 2021. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 12, 2024 Category: Pharmaceuticals Authors: Ryan Sharrow Source Type: news
